Acute caffeine administration decreased NOS and Bcl2 expression in rat skeletal muscles

Giovanni Corsetti, Evasio Pasini, Deodato Assanelli, Elisa Saligari, Massimo Adobati, Rossella Bianchi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Caffeine (Caf) is largely used to delay fatigue, improving physical activity. However, its role remains elusive, and there are no hemodynamic or immunohistochemical data regarding its effects on skeletal muscle. We studied the hemodynamic and NOS expression of Bax/Bcl2 in skeletal muscle after single Caf administration. Thirty-two male rats were divided into six groups: the first was iv-injected with Caf (16 mg/kg), the second with Caf + L-NAME, the third with Caf + L-arg, the fourth with Caf + L-NAME + L-arg, fifth with saline. Mean arterial blood pressure (MAP) was monitored for 30′, then the animals were killed. The sixth group was injected with Caf and killed after 2 h. The quadriceps were isolated and processed by immunohistochemistry. We found that Caf increased MAP temporarily, while Caf + L-NAME increased it for a longer period. In untreated muscle, all NOS isoforms was expressed with different intensity and localisation, and Bcl2 was strongly expressed among the myofibrils. In Caf and Caf + L-NAME treated animals, NOS expression was lost; Bcl2 expression decreased among myofibrils but increased inside the subsarcolemma. The L-arg administration reversed these Caf and L-NAME effects. Two hours after Caf, NOS expression increased. We concluded that improved physical performance could be related to Caf's ability to interfere with the endogenous muscular synthesis of NO.

Original languageEnglish
Pages (from-to)96-103
Number of pages8
JournalPharmacological Research
Volume55
Issue number2
DOIs
Publication statusPublished - Feb 2007

Fingerprint

Caffeine
Skeletal Muscle
NG-Nitroarginine Methyl Ester
Arterial Pressure
Myofibrils
Hemodynamics
Fatigue
Protein Isoforms
Immunohistochemistry

Keywords

  • Apoptosis
  • Caffeine
  • Hemodynamic
  • Nitric oxide
  • Rat
  • Skeletal muscle

ASJC Scopus subject areas

  • Pharmacology

Cite this

Acute caffeine administration decreased NOS and Bcl2 expression in rat skeletal muscles. / Corsetti, Giovanni; Pasini, Evasio; Assanelli, Deodato; Saligari, Elisa; Adobati, Massimo; Bianchi, Rossella.

In: Pharmacological Research, Vol. 55, No. 2, 02.2007, p. 96-103.

Research output: Contribution to journalArticle

Corsetti, Giovanni ; Pasini, Evasio ; Assanelli, Deodato ; Saligari, Elisa ; Adobati, Massimo ; Bianchi, Rossella. / Acute caffeine administration decreased NOS and Bcl2 expression in rat skeletal muscles. In: Pharmacological Research. 2007 ; Vol. 55, No. 2. pp. 96-103.
@article{5bdd3a31931841d88024bc3ce059cfb8,
title = "Acute caffeine administration decreased NOS and Bcl2 expression in rat skeletal muscles",
abstract = "Caffeine (Caf) is largely used to delay fatigue, improving physical activity. However, its role remains elusive, and there are no hemodynamic or immunohistochemical data regarding its effects on skeletal muscle. We studied the hemodynamic and NOS expression of Bax/Bcl2 in skeletal muscle after single Caf administration. Thirty-two male rats were divided into six groups: the first was iv-injected with Caf (16 mg/kg), the second with Caf + L-NAME, the third with Caf + L-arg, the fourth with Caf + L-NAME + L-arg, fifth with saline. Mean arterial blood pressure (MAP) was monitored for 30′, then the animals were killed. The sixth group was injected with Caf and killed after 2 h. The quadriceps were isolated and processed by immunohistochemistry. We found that Caf increased MAP temporarily, while Caf + L-NAME increased it for a longer period. In untreated muscle, all NOS isoforms was expressed with different intensity and localisation, and Bcl2 was strongly expressed among the myofibrils. In Caf and Caf + L-NAME treated animals, NOS expression was lost; Bcl2 expression decreased among myofibrils but increased inside the subsarcolemma. The L-arg administration reversed these Caf and L-NAME effects. Two hours after Caf, NOS expression increased. We concluded that improved physical performance could be related to Caf's ability to interfere with the endogenous muscular synthesis of NO.",
keywords = "Apoptosis, Caffeine, Hemodynamic, Nitric oxide, Rat, Skeletal muscle",
author = "Giovanni Corsetti and Evasio Pasini and Deodato Assanelli and Elisa Saligari and Massimo Adobati and Rossella Bianchi",
year = "2007",
month = "2",
doi = "10.1016/j.phrs.2006.10.001",
language = "English",
volume = "55",
pages = "96--103",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",
number = "2",

}

TY - JOUR

T1 - Acute caffeine administration decreased NOS and Bcl2 expression in rat skeletal muscles

AU - Corsetti, Giovanni

AU - Pasini, Evasio

AU - Assanelli, Deodato

AU - Saligari, Elisa

AU - Adobati, Massimo

AU - Bianchi, Rossella

PY - 2007/2

Y1 - 2007/2

N2 - Caffeine (Caf) is largely used to delay fatigue, improving physical activity. However, its role remains elusive, and there are no hemodynamic or immunohistochemical data regarding its effects on skeletal muscle. We studied the hemodynamic and NOS expression of Bax/Bcl2 in skeletal muscle after single Caf administration. Thirty-two male rats were divided into six groups: the first was iv-injected with Caf (16 mg/kg), the second with Caf + L-NAME, the third with Caf + L-arg, the fourth with Caf + L-NAME + L-arg, fifth with saline. Mean arterial blood pressure (MAP) was monitored for 30′, then the animals were killed. The sixth group was injected with Caf and killed after 2 h. The quadriceps were isolated and processed by immunohistochemistry. We found that Caf increased MAP temporarily, while Caf + L-NAME increased it for a longer period. In untreated muscle, all NOS isoforms was expressed with different intensity and localisation, and Bcl2 was strongly expressed among the myofibrils. In Caf and Caf + L-NAME treated animals, NOS expression was lost; Bcl2 expression decreased among myofibrils but increased inside the subsarcolemma. The L-arg administration reversed these Caf and L-NAME effects. Two hours after Caf, NOS expression increased. We concluded that improved physical performance could be related to Caf's ability to interfere with the endogenous muscular synthesis of NO.

AB - Caffeine (Caf) is largely used to delay fatigue, improving physical activity. However, its role remains elusive, and there are no hemodynamic or immunohistochemical data regarding its effects on skeletal muscle. We studied the hemodynamic and NOS expression of Bax/Bcl2 in skeletal muscle after single Caf administration. Thirty-two male rats were divided into six groups: the first was iv-injected with Caf (16 mg/kg), the second with Caf + L-NAME, the third with Caf + L-arg, the fourth with Caf + L-NAME + L-arg, fifth with saline. Mean arterial blood pressure (MAP) was monitored for 30′, then the animals were killed. The sixth group was injected with Caf and killed after 2 h. The quadriceps were isolated and processed by immunohistochemistry. We found that Caf increased MAP temporarily, while Caf + L-NAME increased it for a longer period. In untreated muscle, all NOS isoforms was expressed with different intensity and localisation, and Bcl2 was strongly expressed among the myofibrils. In Caf and Caf + L-NAME treated animals, NOS expression was lost; Bcl2 expression decreased among myofibrils but increased inside the subsarcolemma. The L-arg administration reversed these Caf and L-NAME effects. Two hours after Caf, NOS expression increased. We concluded that improved physical performance could be related to Caf's ability to interfere with the endogenous muscular synthesis of NO.

KW - Apoptosis

KW - Caffeine

KW - Hemodynamic

KW - Nitric oxide

KW - Rat

KW - Skeletal muscle

UR - http://www.scopus.com/inward/record.url?scp=33846647554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846647554&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2006.10.001

DO - 10.1016/j.phrs.2006.10.001

M3 - Article

C2 - 17236787

AN - SCOPUS:33846647554

VL - 55

SP - 96

EP - 103

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 2

ER -